Daniel A. Haber

4 ta ish

Harvard University

1. Gefitinib-Sensitizing <i>EGFR</i> Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

   Raffaella Sordella, Daphne W. Bell, Daniel A. Haber +1

   Maqola20043 iqtibos

   ABIABI:AkademIndex/2026.other.448945

2. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

   Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella +11

   Maqola20042 iqtibos

   ABIABI:AkademIndex/2026.other.592604

3. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

   Wanjuan Yang, Jorge Soares, Patricia Greninger +14

   Maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.782592

4. Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

   James P. Sullivan, Brian V. Nahed, Marissa W. Madden +17

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.806057